Healthcare Experience


Our Healthcare experience includes 738 clients, with 2,757 partnered brands and 693 USAN/INN names. Below is our extensive portfolio, feel free to filter by clients, brands, category or USAN/INN Names.   ||  Click Here for Consumer/B2B Experience



CLIENTS BRANDS CATEGORY
LABOPHARM INC. ACETRAM Pain & Inflammation
LABOPHARM INC. INTELLITAB Medical Device
LABOPHARM INC. TRIDURAL Pain & Inflammation
LEADIANT BIOSCIENCES elapegademase Immunology
LEGOCHEM delpazolid Antibiotic
LEO PHARMA DOVOBET Dermatology
LEO PHARMA ENSTILAR * Dermatology
LEO PHARMA TACLONEX Dermatology
LEO PHARMA TACLONEX SCALP Dermatology
LEO PHARMA X-SYSTO Antibiotic
LEVOLTA PHARMACEUTICALS LEVOLTA PHARMACEUTICALS Corporate Identity
LEXICON PHARMACEUTICALS XERMELO * Gastrointestinal
LFB GROUP FIBCLOT Hematology
LIFESYNCH CHANGING BEHAVIORS, IMPROVING LIVES Service Name
LIGAND PHARMACEUTICALS AVINZA * Pain & Inflammation
LIGAND PHARMACEUTICALS CONBRIZA * Endocrinology
LIGAND PHARMACEUTICALS ONTAK Oncology
LIGAND PHARMACEUTICALS PANRETIN * Dermatology
LIGAND PHARMACEUTICALS TARGRETIN * Oncology
LOGICAL THERAPEUTICS naproxen etemesil Pain & Inflammation
LOMBARD MEDICAL AGILI-D Medical Device
LOXO ONCOLOGY larotrectinib Oncology
LSK BIOPHARMA rivoceranib Oncology
LUITPOLD INJECTAFER * Hematology
LUMINEX CORPORATION FLEXMAP 3D Medical Device
LUMINEX CORPORATION FLEXMIR Medical Device
LUMINEX CORPORATION XPONENT Medical Device
LUNDBECK INC. AZILECT Neurology
LUNDBECK INC. BRINTELLIX * Neurology
LUNDBECK INC. CARNEXIV * Neurology
LUNDBECK INC. CIPRALEX MELTZ * Neurology
LUNDBECK INC. DAYBREAK Clinical Trial Name
LUNDBECK INC. DROXIDOPA Cardiovascular
LUNDBECK INC. idalopirdine Neurology
LUNDBECK INC. ingenol disoxate Oncology
LUNDBECK INC. NORTHERA Neurology
LUNDBECK INC. ONFI Neurology
LUNDBECK INC. SABRIL * Neurology
LUNDBECK INC. tedatioxetine Neurology
LUNDBECK INC. TREANDA * Oncology
LUNDBECK INC. TRINTELLIX * Neurology
LUNDBECK INC. TRISENOX * Oncology
LUNDBECK INC. vortioxetine Neurology
Lycera parimifasor Pain & Inflammation


* Denotes a comprehensive report of the safety regulatory research prepared by BI/DSI for submission of this name candidate to FDA, EMA, Health Canada, JMHLW, ANVISA, ROSZDRAVNADZOR, CDSCO, CFDA, KOREA MFDS, and/or other Regulatory Agencies.

Back to top